Mayo Research into Microbiome-Nutrition Connection Lands ADM’s Backing
Mayo Research into Microbiome-Nutrition Connection Lands ADM’s Backing

New collaboration is clinic’s second in emerging personalized wellness field.

Celcuity Becomes Third MN Company to Go Public This Year
Celcuity Becomes Third MN Company to Go Public This Year

The biotechnology company officially kicked off its IPO on Wednesday.

Medtronic Launches Platform with Unique Approach to Treating Chronic Pain
Medtronic Launches Platform with Unique Approach to Treating Chronic Pain

Instead of prescribing an opioid-based treatment plan, the Intellis system offers doctors a non-opioid approach to treating chronic back pain.

OneOme Expands its Global Reach to Japan, Hong Kong and Macau
OneOme Expands its Global Reach to Japan, Hong Kong and Macau

The startup’s personalized medicine test offers a unique potential in Asia, where people take similar medications to Americans and Europeans but don’t share the same genetic makeup.

U of M Lands Patent for Using Synthetic DNA to Target Heart Failure
U of M Lands Patent for Using Synthetic DNA to Target Heart Failure

Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.

Newly Launched CoreBiome Touts Microbiome ‘Profiling’ Services
Newly Launched CoreBiome Touts Microbiome ‘Profiling’ Services

U of M spinoff has tech to analyze microbial communities for health, ag clients.

FDA Claims Entellus Medical Broke Protocol During 2015 Study
FDA Claims Entellus Medical Broke Protocol During 2015 Study

The Plymouth-based company was testing a product used to treat dysfunctions in the Eustachian tube in the nose.

Rebiotix Seeks $10M in Funding Round

The company is developing treatments for gastrointestinal issues that use human gut bacteria.

Medtech Legend Manny Villafaña Opens $15M Funding Round for Medical 21
Medtech Legend Manny Villafaña Opens $15M Funding Round for Medical 21

If fundraising efforts (and an animal testing round) are successful, the founder of St. Jude Medical and Guidant said his latest startup will move forward to testing its artificial blood vessel on humans.